DNAJC2 and triple-negative breast carcinoma: We next addressed if ZRF1 depletion promotes resistance to cell death in triple negative breast cancers (TNBC) which are biologically more aggressive than ER (+) breast cancers and are responsive to chemotherapeutic reagents such as platinum compounds [56].